logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

R. Descourt

chu brest
H指数:18
被引数:1,495

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study

法国早期准入项目中阿曼曲单抗在EGFR外显子20突变非小细胞肺癌中的真实世界有效性与安全性：Amexon 20 GFPC研究

Lung Cancer
IF4.4
2025-09-260
PRE
Thomas Pierret; Laurent Greillier; Florian Guisier; Catherine Daniel; Renaud Descourt; Loick Galland; Olivier Molinier; Chantal Decroisette; Alexis Cortot; Diane Moreau; Laurence Bigay Gamé; Marie Wislez; Nicolas Cloarec; Hubert Curcio; Nicolas Delberghe; Jacques Cadranel; Boris Duchemann; Anne Claire Toffart; Christos Chouaïd; Jean-Bernard Auliac
First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018)

一线帕博利珠单抗在PD-L1表达≥50%的80岁及以上非小细胞肺癌患者中的疗效（ESCKEYP GFPC 05-2018）

Clinical Lung Cancer
IF3.3
2025-03-040
PRE
Romain Corre; Chantal Decroisette; Jean-Bernard Auliac; Lionel Falchero; Hubert Curcio; Karim Amrane; Maurice Perol; Stéphane Hominal; Sabine Vieillot; Eric Huchot; Anne Laure Desage; Marie Bernardi; Remi Veillon; Hélène Doubre; Suzanna Bota; Gwenaelle Legarff; Grégoire Justeau; Oliver Bylicki; Magali Roa; Renaud Descourt; Christos Chouaïd; Laurent Greillier
A national real-world analysis of ROS1+metastatic non-small cell lung cancer patients management (explore ALK, cohort 2, GFPC 03-2019)

一项关于ROS1+转移性非小细胞肺癌患者管理的全国性真实世界分析（探索ALK，队列2，GFPC 03-2019）

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Bussac, G. Rousseau; Guisier, F.; Veillon, R.; Doubre, H.; Cortot, A. B.; Moreau, L.; Pierret, T.; Falchero, L.; Justeau, G.; Ricordel, C.; Morel, H.; Amrane, K.; Bigay-Game, L.; Hominal, S.; Martinez, S.; Renault, P. A.; Moreau, D.; Marcq, M.; Descourt, R.; Greillier, L.
Explore-ALK (GFPC 03-2019): A real-world prospective, multicenter study of advanced ALK rearranged non-small cell lung cancer patients

探索-ALK (GFPC 03-2019)：一项真实世界前瞻性、多中心研究，探讨ALK重排的非小细胞肺癌患者

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Decroisette, C.; Descourt, R.; Bussac, G. Rousseau; Swalduz, A.; Bylicki, O.; Bigay-Game, L.; Doubre, H.; Cortot, A. B.; Hominal, S.; Falchero, L.; Guisier, F.; Domblides, M.; Lamy, R.; Pinsolle, J.; Ricordel, C.; Moreau, D.; Martinez, S.; Justeau, G.; Chouaid, C.; Greillier, L.
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)
TARGETED ONCOLOGY
IF4
2023-11-151
PRE
Dhamelincourt, Estelle; Descourt, Renaud; Rousseau-Bussac, Gaelle; Doubre, Helene; Decroisette, Chantal; Demontrond, Pierre; Le Garff, Gwenaelle; Falchero, Lionel; Huchot, Eric; Vieillot, Sabine; Corre, Romain; Kazulinski, Laure; Bizieux, Acya; Bigay-Game, Laurence; Morel, Hugues; Molinier, Olivier; Chouaid, Christos; Guisier, Florian
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)
JOURNAL OF IMMUNOTHERAPY
IF2.9
2023-10-090
PRE
Decroisette, Chantal; Greillier, Laurent; Curcio, Hubert; Perol, Maurice; Ricordel, Charles; Auliac, Jean-Bernard; Falchero, Lionel; Veillon, Remi; Vieillot, Sabine; Guisier, Florian; Marcq, Marie; Justeau, Gregoire; Bigay-Game, Laurence; Bernardi, Marie; Doubre, Helene; Pinsolle, Julian; Amrane, Karim; Chouaid, Christos; Descourt, Renaud
The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor

1825-碱性EORTC: 基于先前接受第二代ALK抑制剂治疗的ALK阳性NSCLC患者血液中ALK耐药突变的洛拉替尼活性

ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Mezquita, L.; Xenophontos, E.; Pretzenbaher, Y.; Sureda, C.; Nadal, E.; Al-Rabi, K.; Bussac, G. Rousseau; Aix, S. Ponce; Sullivan, I. G.; Blanco, A. Calles; Cloarec, N.; De langen, J.; Berghmans, T.; Descourt, R.; Hendriks, L.; Lopez, P. Garrido; Helland, A.; Carcereny, E.; Besse, B.; Dingemans, A-M. C.
Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1=50% (GFPC 01-20 Study)

简要报告: 具有MET外显子14跳跃突变且PD-L1 = 50% 的转移性非小细胞肺癌的一线Pembrolizumab (GFPC 01-20研究)

CLINICAL LUNG CANCER
IF3.3
2022-12-0110
OAAI
Guisier, Florian; Descourt, Renaud; Babey, Helene; Huchot, Eric; Falchero, Lionel; Veillon, Remi; Cortot, Alexis B.; Tissot, Claire; Chouaid, Christos; Decroisette, Chantal
Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2022-06-066
OAAI
Bilger, Geoffroy; Toffart, Anne-Claire; Darrason, Marie; Duruisseaux, Michael; Ulmer, Lucie; Wang, Pascal; Leprieur, Etienne Giroux; Girard, Nicolas; Massiani, Marie Ange; Bore, Paul; Descourt, Renaud; Pinsolle, Julian; Valery, Solene; Monnet, Isabelle; Swalduz, Aurelie; Tissot, Claire; Fournel, Pierre; Baranzelli, Anne; Cortot, Alexis B.; Decroisette, Chantal

研究方向

暂未获取到该数据
C
C. Chouaïd
H 指数:58论文数:1,032被引数:1.8万
F
Florian Guisier
H 指数:28论文数:231被引数:3,781
H
H. Doubre
H 指数:17论文数:119被引数:1,398
C
C. Decroisette
H 指数:19论文数:188被引数:2,113
A
Alexis B. Cortot
H 指数:44论文数:500被引数:1.1万
L
Laurent Greillier
H 指数:41论文数:498被引数:9,237
G
Gilles Quéré
H 指数:20论文数:92被引数:1,883
B
B. Mennecier
H 指数:21论文数:158被引数:4,086
G
G. Robinet
H 指数:34论文数:230被引数:1.4万
L
L. Falchero
H 指数:24论文数:217被引数:2,985